Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This therapeutic combination is a specialized mixture used for ultrasound-guided hydrodilatation in the treatment of shoulder adhesive capsulitis (frozen shoulder). Utilized in clinical research at Tanta University, the mixture typically consists of a corticosteroid, sterile saline (sodium chloride), and lidocaine. The corticosteroid component serves to reduce intra-articular inflammation and suppress the formation of new adhesions, while lidocaine acts as a local anesthetic to provide immediate pain relief during and after the procedure. The saline component provides the volume necessary for mechanical distension (hydrodilatation) of the contracted glenohumeral joint capsule. By physically stretching the capsule and delivering anti-inflammatory agents directly to the site of pathology, this combination therapy aims to improve range of motion and reduce chronic pain in patients who have failed conservative management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on corticosteroid + lidocaine + sodium chloride.